Locations:
Search IconSearch

Psychogenic Nonepileptic Seizures: What Neurologists Need to Know (Podcast)

Two experts share diagnostic and treatment essentials on a sensitive, poorly understood condition

About three of every 10 patients evaluated in Cleveland Clinic’s epilepsy monitoring unit are diagnosed with psychogenic nonepileptic seizures (PNES). Despite being so prevalent, the condition is poorly understood by some providers and the diagnosis is difficult for some patients to accept. Yet effective treatment is possible with the right collaborative expertise.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

In the latest episode of Cleveland Clinic’s peer-to-peer Neuro Pathways podcast, neurologist Jocelyn Bautista, MD, and clinical psychologist Becky Bikat Tilahun, PhD, share their PNES expertise in an effort to bring some clarity to this complex condition. The ground they cover includes:

  • What causes PNES and how it differs from epilepsy
  • When and why clinicians might suspect PNES in a patient with seizures
  • What the evaluation for PNES involves
  • Considerations for presenting the PNES diagnosis to a patient
  • What’s necessary for effective treatment of PNES

Click the player below to listen to the 19-minute podcast now, or read on below for a short edited excerpt of the discussion. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Dr. Alex Rae-Grant (podcast host): I expect that presenting a diagnosis of PNES to a patient needs to be handled somewhat delicately. How do you approach that in your practice?

Dr. Bautista: Typically we deliver this diagnosis in the epilepsy monitoring unit, after we’ve recorded the episodes in question. Every physician has a different style and different phrases or analogies we might use. But the main message we want to convey is that these are real symptoms and that this is a condition that we see quite a lot. As you mentioned earlier, 30% of our patients in the monitoring unit are diagnosed with PNES. So this is certainly a condition that we’ve seen and treated and it can get better.

It’s important to try to make the connection between emotions and psychological distress and how that can be converted to physical symptoms such as nonepileptic seizures. And it’s incredibly important to take your time and to deliver the diagnosis with empathy for what the patient has been through and what this has done to their life, and to be as patient as possible and constantly checking to confirm their understanding after you’ve explained something.

Advertisement

So it does take time, but it’s crucial. Delivering the diagnosis effectively can actually be therapeutic in the short term. Whereas if it’s not delivered effectively, the patient can go away angry and the seizures will likely get worse.

Advertisement

Related Articles

Physical therapist helping patient walk with a powered exoskeleton and walker

Exoskeleton-Aided Physical Therapy Proves Feasible in MS

Study looked at mobility measures and safety

portrait of Dr. Kriti Bhayana against decorative background with podcast overlay
April 2, 2026/Neurosciences/Podcast

Practice Essentials for Pediatric and Perinatal Stroke (Podcast)

Types and presentation may differ from adults, but early recognition and intervention are just as key

Two-dimensional scatter plot of peak T1 versus T2 times from pre-extended lumbar drainage MRI

MR Fingerprinting Predicts Shunt Efficacy in NPH

Study tests potential for a more accurate treatment predictor

person going into a Gamma Knife machine for radiotherapy
March 25, 2026/Neurosciences/Brain Tumor

Predicting Response to Stereotactic Radiosurgery for Recurrent Glioblastoma

Study uses molecular and clinical stratification to help guide patient selection

illustration of human brain with rumor at top right
March 23, 2026/Neurosciences/Brain Tumor

Adding Eflornithine to Lomustine Extends Survival in Recurrent IDH-Mutant Grade 3 Astrocytoma

Phase 3 STELLAR trial underscores role of molecular stratification in glioma care

brain MRI taken from the back of the head
March 20, 2026/Neurosciences/Epilepsy

Unmasking the ‘Tethered’ Temporal Lobe: New MRI Metrics Improve Detection of Encephaloceles in Refractory Epilepsy

Early identification of temporal encephaloceles can improve surgical decision-making

brain scan with white lesion on right side

ARISE II Recommendations Chart a Course for Advancing Intracranial Hemorrhage Care

Academia, industry and government leaders develop consensus priorities

two brain scans side by side with a yellow circle on the left scan
March 13, 2026/Neurosciences/Epilepsy

SEEG Linked With More Complete Resection and Greater Seizure Freedom in MOGHE Subtype of Epilepsy

Insights from one of the first studies of invasive monitoring in the rare form of focal cortical dysplasia

Ad